Eli G. Dib: I’ve received a 5-year NCI Clinician Scientist R-50 award from the NCI
Eli G. Dib shared on LinkedIn:
“I am thrilled to share that I’ve received a 5-year NCI Clinician Scientist R-50 award from the National Cancer Institute (NCI)!
The project, ‘Research Capacity Building by a Clinician Scientist within the Michigan Cancer Research Consortium- National Community Oncology Research Program,’ will be carried out at Trinity Health MI and IHA, where our dedicated team advances cancer care in our communities.
I’m deeply grateful for the National Cancer Institute (NCI) for this recognition and the opportunity to contribute to cancer research and patient care over the next five years. This sustained support will help us push forward with clinical trials and innovative treatments. Together, we’re bringing hope to those affected by cancer.”
Read Further.
Source: Eli G. Dib/LinkedIn
Dr. Elie G. Dib, MD, MS, FACP, is a Hematologist-Oncologist and Course Director at the Society for Immunotherapy of Cancer (SITC). He is also part of the medical team at IHA and adjunct faculty at Johns Hopkins University, where he teaches Cancer Genomics to graduate students in the Advanced Academic Programs. Dr. Dib is the NCORP Representative on the NCI Genitourinary Cancers Steering Committee (GUSC) and is involved in multiple roles with the American Society of Clinical Oncology (ASCO).
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023